Nov 15, 2021 7:30 am EST MindMed Announces Financial Results for the Third Quarter 2021 and Business Highlights; Cash Balance of $145.9 USD ($185.4 CAD) to Execute on Diverse Clinical Pipeline
Oct 26, 2021 7:00 am EDT MindMed Expands its Drug Development Pipeline with Launch of R(-)-MDMA Program
Sep 30, 2021 7:30 am EDT MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors and Transition of Bruce Linton
Sep 29, 2021 7:30 am EDT MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan Roth to Scientific Advisory Board